NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
NOVAFERON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
04/30/2025
Trademark type
Word
Nice classes
1, 5
Filing date
12/18/2018
Registration date
11/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2023
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
George Town, KY
Examiner
KEATING,SHANNON B
Current location
Historical data usage
Holders and representatives
Holders
Novagen Holding Corporation
Representatives
Kevin S. Costanza SEED IP LAW GROUP LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein fragments for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; protein conjugates for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; anti-cancer and anti-viral agents for use in the manufacture of pharmaceutical preparations for treating cancer and viral diseases; proteinsprotein fragmentsprotein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseasesparticularly autoimmune diseases
Class 5
Pharmaceutical preparations for treatment of cancer and viral diseases; proteins for treatment of cancer and viral diseases; protein fragments for treatment of cancer and viral diseases; protein conjugates for treatment of cancer and viral diseases; pharmaceutical preparationsanti-cancer and anti-viral agents; pharmaceutical preparationsproteinsprotein fragments and protein conjugates all for treatment of immunologic diseasesparticularly autoimmune diseases
Publications
History of USPTO decisions and trademark events.
61 publications found
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/27/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/25/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/05/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/30/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/23/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2023
PUBO
PUBLISHED FOR OPPOSITION
08/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
OTHE
CASE RETURNED TO EXAMINATION
07/19/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/19/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/18/2023
APET
ASSIGNED TO PETITION STAFF
07/10/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
06/21/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/27/2023
EX5G
SOU EXTENSION 5 GRANTED
01/26/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/26/2023
EXT5
SOU EXTENSION 5 FILED
01/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/23/2022
EX4G
SOU EXTENSION 4 GRANTED
07/21/2022
EXT4
SOU EXTENSION 4 FILED
07/21/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/21/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/22/2022
EX3G
SOU EXTENSION 3 GRANTED
01/20/2022
EXT3
SOU EXTENSION 3 FILED
01/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/21/2021
EX2G
SOU EXTENSION 2 GRANTED
07/19/2021
EXT2
SOU EXTENSION 2 FILED
07/19/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/19/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/19/2021
EX1G
SOU EXTENSION 1 GRANTED
01/15/2021
EXT1
SOU EXTENSION 1 FILED
01/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/09/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2020
PUBO
PUBLISHED FOR OPPOSITION
05/26/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/02/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/04/2019
GNFR
FINAL REFUSAL E-MAILED
10/04/2019
CNFR
FINAL REFUSAL WRITTEN
10/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/20/2019
GNRT
NON-FINAL ACTION E-MAILED
03/20/2019
CNRT
NON-FINAL ACTION WRITTEN
03/20/2019
DOCK
ASSIGNED TO EXAMINER
03/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/10/2019
NWAP
NEW APPLICATION ENTERED
12/21/2018
Continuous trademark protection
Get notified about every new filing that threatens NOVAFERON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.